CLINICAL_TRIALS
trial_result
· 2026-04-06
Clinical Trial Update: Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder [Phase 2]
Summary
Phase 2 clinical trial assessing measures of acute psychomotor agitation in people with schizophrenia and bipolar disorder has completed. The study is sponsored…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: BioXcel Therapeutics Inc | Conditions: Bipolar I Disorder, Bipolar II Disorder | Phase 2 | Status: COMPLETED